Alaunos Therapeutics, Inc.
TCRT
$4.29
$0.2947.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 319.00K | 1.09M | 1.68M | 2.46M | 4.15M |
| Total Receivables | 2.00K | 5.00K | -- | 4.00K | 1.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 746.00K | 1.66M | 1.87M | 2.21M | 1.89M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.07M | 2.76M | 3.55M | 4.68M | 6.04M |
|
|
|||||
| Total Current Assets | 1.07M | 2.76M | 3.55M | 4.68M | 6.04M |
| Net Property, Plant & Equipment | -- | 0.00 | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.05M | -- | -- | -- | -- |
| Total Assets | 2.12M | 2.76M | 3.55M | 4.68M | 6.04M |
|
|
|||||
| Total Accounts Payable | 831.00K | 516.00K | 458.00K | 365.00K | 597.00K |
| Total Accrued Expenses | 231.00K | 176.00K | 368.00K | 542.00K | 643.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.06M | 692.00K | 826.00K | 907.00K | 1.24M |
|
|
|||||
| Total Current Liabilities | 1.06M | 692.00K | 826.00K | 907.00K | 1.24M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.06M | 692.00K | 826.00K | 907.00K | 1.24M |
|
|
|||||
| Common Stock & APIC | 922.58M | 922.51M | 922.43M | 922.35M | 922.25M |
| Retained Earnings | -921.52M | -920.45M | -919.70M | -918.58M | -917.45M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 1.06M | 2.06M | 2.72M | 3.77M | 4.80M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.06M | 2.06M | 2.72M | 3.77M | 4.80M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.06M | 2.06M | 2.72M | 3.77M | 4.80M |
|
|
|||||